Will weight loss become a future treatment of hepatocellular adenoma in obese patients

摘要: Background & Aims Although hepatocellular adenoma (HCA) is more frequently observed in obese patients, however, the effect of weight loss as a therapeutic option was never studied. Methods In this rapid communication we described our non-surgical management large HCA (>5 cm) encountered patients with morbid obesity. Non-surgical consisted mainly oral contraception withdrawal and loss, which only two patients. All demographics, radiological histological data were studied. Patients followed regularly every 6 months. Results Between 2004 2013, 116 presented 15 obesity (13%) Five men underwent surgery females either operated (period before 2010; n = 5) or proposed to after n = 5).Weight advocated all females, including four residual resection non-operated haemorrhagic HCA. Four (40%) showed significant loss. In resected allowed stability (n = 1) slight regression treated by decrease (>50%) size number (<5 cm). Severe morbidity 40% 0% After follow-up period 38 months (18–60), no complication degeneration group. Conclusion Like contraception, should be considered first